Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa

Figures & data

Figure 1. a) Erythema, scaling and alopecia on the scalp of a 46-year-old woman after 22 weeks of treatment with adalimumab; b) complete remission of the alopecia after 16 weeks of treatment with ixekizumab.

Figure 2. a-b) Paradoxical pustular psoriasis of the soles, emerging after 22 weeks of treatment with adalimumab; c) complete skin clearance after 16 weeks of treatment with ixekizumab.